Reuters logo
BRIEF-Flex Pharma Q1 loss per share $0.49
2017年5月3日 / 上午11点19分 / 5 个月前

BRIEF-Flex Pharma Q1 loss per share $0.49

May 3 (Reuters) - Flex Pharma Inc

* Flex pharma reports first quarter 2017 financial results

* Q1 loss per share $0.49

* Q1 revenue $243,000

* Q1 revenue view $350,000 -- Thomson Reuters I/B/E/S

* Q1 earnings per share view $-0.62 -- Thomson Reuters I/B/E/S

* Flex pharma inc- fda clears ind for flx-787 to commence us phase 2 trial in als

* Flex pharma inc - fda clears ind for flx-787 to commence us phase 2 trial in als

* Flex pharma inc- us phase 2 trials in als and cmt expected to commence summer 2017

* Flex pharma inc - us phase 2 trials in als and cmt expected to commence summer 2017

* Flex pharma inc - expects to have sufficient capital to fund its operations into early 2019 Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below